Skip to main content
Log in

Pharmacokinetics and Dosage Regimen of Enrofloxacin in Buffalo Bulls after Intramuscular Administration

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

The disposition kinetics and dosage regimen of enrofloxacin were investigated in breeding buffalo bulls following a single intramuscular administration of 5 mg/kg. The absorption half-life, half-life of the terminal phase, apparent volume of distribution and total body clearance were 0.262±0.099 h, 1.97±0.23 h, 0.61±0.13 L/kg and 210.2±18.6 ml/(kg.h), respectively. Therapeutic plasma levels (≥1 μg/ml) were maintained for up to 6 h. A satisfactory intramuscular dosage regimen for enrofloxacin in buffalo bulls would be 8.5 mg/kg followed by 8.0 mg/kg at 8 h intervals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Ahangar, A.A., 1998. Effect of fever on pharmacokinetics and dosage regimen of enrofloxacin in cow calves, (MVSc thesis, Punjab Agricultural University, Ludhiana, India)

    Google Scholar 

  • Altreuther, P., 1987. Data on chemistry and toxicology of Baytril. Veterinary Medicine Review, 2, 87—89

    Google Scholar 

  • Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: Second Revision. Journal of Pharmaceutical Science, 60, 1689—1694

    Google Scholar 

  • Baggot, J.D., 1977. Principles of drug disposition in domestic animals. In: J.D. Baggot (ed.), The Basis of Veterinary Clinical Pharmacology, (W.B. Saunders, Philadelphia), 144—189

    Google Scholar 

  • Bauditz, R., 1990. Enrofloxacin — clinical evaluation in several animals. In: F. Siman, P. Lees and G. Semjen (eds),Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 21—26

    Google Scholar 

  • Cabanes, A., Arboix, M., Gracia, J.M. and Reign, F., 1992. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090—2093

    Google Scholar 

  • Dowling, P.M., Wilson, R.C., Tyler, J.W. and Duran, S.H., 1995. Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7—12

    Google Scholar 

  • Gandorfer, B., 1991. Pharmacokinetics of Baytril (enrofloxacin), particularly passage from blood to milk, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 104

    Google Scholar 

  • Gatne, M.M. and Ranade,V.V., 1996. Enrofloxacin — a new drug. The Blue Cross Book, 6, 26—28

    Google Scholar 

  • Gibaldi, M. and Perrier, D., 1982. Appendix C: Method of residuals. Pharmacokinetics, (Marcel Dekker, New York), 433—444

    Google Scholar 

  • Kuhn, H., 1993. Pharmacokinetic studies on the gyrase inhibitors enrofloxacin and ofloxacin, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 214

    Google Scholar 

  • Kung, K., Riond, J.L. and Wanner, M., 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462—468

    Google Scholar 

  • Prescott, J.F. and Yielding, K.M., 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195—197

    Google Scholar 

  • Scheer, M., 1987. Studies on the antimicrobial activity of Baytril. Veterinary Medicine Review, 2, 90—99

    Google Scholar 

  • Steeve, G., Raymond,W.S. and Myriam, B., 1996. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 7, 1025—1030

    Google Scholar 

  • Vancutsem, M., Babish, J.G. and Schwark, W.S., 1990. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinarian, 80, 173—186

    Google Scholar 

  • Zehe, V., 1990. Pharmacokinetics of DNA gyrase inhibitor enrofloxacin in horses, (Inaugural dissertation, Tierarztliche Hochschule, Hannover; CAB Abstract 060–05812)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verma, H., Pangawkar, G., Chaudhary, R. et al. Pharmacokinetics and Dosage Regimen of Enrofloxacin in Buffalo Bulls after Intramuscular Administration. Vet Res Commun 23, 501–505 (1999). https://doi.org/10.1023/A:1006366507016

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006366507016

Navigation